EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    The Unprecedented Surge of Biopharmaceuticals in the European Market

    Recent years have seen a significant upheaval in the European pharmaceutical scene marked by an unparalleled surge in biopharmaceutical prominence This shift isnt fleeting but signifies a profound and enduring transformation To fully grasp this paradigm shift its essential to explore the complex interplay of scientific advancements market dynamics regulatory frameworks economic factors and global...

    From Digital Transformation to Intelligent Pharma: How AI Is Reshaping Pharmaceutical Strategy

    Pharmas digital transformation has solved one problem well access to information Market signals arrive continuously Commercial teams generate customer and channel data medical and scientific functions accumulate new evidence and supply and finance teams produce operational signals that enterprise platforms can now connect across what were once separate systems

    Digital Twins in Pharmaceutical R&D: Simulating Biology for Faster Innovation

    For most of its modern history pharmaceutical research has been an experimental science with a statistical conscience Build the molecule dose the animal run the trial count the failures and let the survivors pay for everything that did not make it That arrangement has become progressively harder to defend Attrition remains concentrated in the phases where money has already

    How Good Clinical Practice (GCP) Compliance Shapes Pharma Success?

    Good Clinical Practice GCP compliance is a cornerstone of pharmaceutical research and development ensuring that clinical trials are conducted ethically with participant safety as the top priority

    Ethical Sourcing in Pharma: Top Strategies for Sustainable Supply Chains in 2026

    Pharmaceutical business is moving into a decisive decade in which ethical sourcing has ceased being a corporate value of goodwill and has become a strategic need Pharma ethical sourcing is closely connected to business continuity regulatory compliance environmental stewardship and brand trust in With supply chains that are increasingly global fragmented and vulnerable to geopolitical climatic and...

    The Role of Technology in Enhancing Patient Acceptance and Satisfaction

    Technology has revolutionized every aspect of our lives and healthcare is no exception From electronic health records EHRs to telemedicine and wearable devices advancements in technology

TOP ARTICLES

press releases Read more...

Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy

Climb Bio Inc Nasdaq CLYM a clinicalstage biotechnology company developing therapeutics for patients with immunemediated diseases today announced positive initial data from the ongoing

Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program

Applied Biologics a biopharmaceutical company advancing novel therapies for serious diseases with significant unmet medical needs today announced an important preclinical milestone in its DiseaseModifying

HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment

HCW Biologics Inc the Company or HCW Biologics NASDAQ HCWB a USbased clinicalstage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune

UniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

UniQure NV NASDAQ QURE a leading gene therapy company advancing transformative therapies for patients with severe medical needs today announced the submission of a Biologics License Application

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

Kali Therapeutics Receives U.S. FDA Clearance for KT501 Clinical Trial

Kali Therapeutics a clinicalstage biotechnology company developing immuneresetting and multispecific therapies has received clearance from the US Food and Drug Administration FDA for its Investigational New

Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development

Genedata has expanded its collaboration with Abcam to strengthen antibody development and support the use of artificial intelligence AI across Abcams global research and development operations

Evotec and Plectonic Enter Research Collaboration to Explore New T-Cell-Engaging Approaches for Solid Tumours

Evotec SE and Plectonic Biotech have entered a research collaboration to explore a new immunotherapy approach for solid tumours The partnership will combine Plectonics programmable LOGIBODY

NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy

NewBiologix SA and Synastra Biotechnology Inc have entered into an agreement to develop a stable producer cell line for Synastras investigational gene therapy programme for Duchenne muscular dystrophy DMD

Styx Biotechnologies and ZoeNCure Therapeutics Sign Strategic Agreement to Advance ADC Pipeline

Styx Biotechnologies a San Diegobased biotechnology company developing nextgeneration antibodydrug conjugates ADCs for solid tumours has entered into a strategic agreement with ZoeNCure Therapeutics Pvt Ltd to advance selected ADC programmes towards firstinhuman clinical trials

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Expands Executive Leadership Team

Vertex Pharmaceuticals Incorporated Nasdaq VRTX has completed its acquisition of Crinetics Pharmaceuticals Inc Nasdaq CRNX a pharmaceutical company focused on developing treatments for endocrine diseases Vertex has also expanded its executive leadership team as it continues to grow and diversify its...